The General Assembly of the Holding Company for Pharmaceuticals, Chemicals and Medical Appliances, affiliated to the Ministry of Public Business Sector, approved The independent and consolidated financial statements of the holding company for the fiscal year ending on 30/6/2021.
Dr. Ashraf El-Khouly, Executive Director of the Holding Company for Pharmaceuticals, presented, during the assembly, Board of Directors report for the fiscal year 2020/2021, The consolidated financial statements showed activity revenues of 5.6 billion pounds and a net profit of 378 million pounds.
The planned and actual development stages of the subsidiaries to achieve the requirements of GMP (Good Manufacturing Practices) were also reviewed. Where the first and second phases were completed over the course of the fiscal year 2020/2021 until the end of March 2022, with a total of about EGP 381 million, The third phase is scheduled to be completed during the fiscal year 2022/2023, with a value of 1.4 billion pounds.
and about the digital transformation project, The installation of ERP software has been completed in my first phase companies (Sid, Nile) and is currently under actual operation, Preparations are also underway to start implementing the second phase of the project.
